chemotherapy

systematic review meta-analysis network meta-analysis

Select lung cancer (metastatic) All type of patient       pemetrexed alonepemetrexed doublet vandetanib pemetrexed      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results	objective response (ORR) (5)death (overall survival) (4)progression or death (progression free survival PFS) (4) Options Numeric bar chart forest plot medians
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	objective response (ORR)	death (overall survival)
lung cancer (metastatic)
pemetrexed
Chen, 2008	pemetrexed	docetaxel				-
Hanna, 2004	pemetrexed	docetaxel				-
Li, 2012	pemetrexed	docetaxel				-
Sun, 2013      NCT	pemetrexed	docetaxel				-
Jose, 2011	pemetrexed plus carboplatin	docetaxel plus carboplatin				-
Socinski, 2010      NCT	pemetrexed plus carboplatin	docetaxel plus carboplatin				-
Smit, 2009	pemetrexed plus carboplatin	pemetrexed				suggesting
vandetanib
De Boer, 2011	vandetanib plus pemetrexed	pemetrexed				negative